Author

L. Skintemo

Institution: Isofol (Sweden)

Observed institution: Isofol (Sweden)

OpenAlex ID: A5028974841

A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer

2022 · G. Carlsson, A. Koumarianou, et al. · ESMO Open · 3

ISO-CC-005; A phase I/II study of arfolitixorin (MTHF) in combination with 5-FU, irinotecan, and oxaliplatin ± bevacizumab in patients with metastasizing colorectal cancer

2018 · G.U. Carlsson, T.K. Guren, et al. · Annals of Oncology · 1

33P Final analysis of the Greek cohort of the AGENT phase III study arfolitixorin in metastatic colorectal cancer

2024 · A. Koumarianou, E. Bournakis, et al. · Annals of Oncology

Works count: 3

Citation count: 4

H-index: 1

I10-index: